Singapore markets closed

Carisma Therapeutics, Inc. (CARM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1900-0.1100 (-8.46%)
At close: 04:00PM EDT
1.2299 +0.04 (+3.35%)
Pre-market: 08:50AM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.90%
S&P500 52-week change 323.99%
52-week high 39.7660
52-week low 31.1600
50-day moving average 31.6707
200-day moving average 32.8421

Share statistics

Avg vol (3-month) 3172.37k
Avg vol (10-day) 3188.9k
Shares outstanding 541.54M
Implied shares outstanding 641.54M
Float 822.5M
% held by insiders 128.68%
% held by institutions 139.63%
Shares short (15 May 2024) 41.57M
Short ratio (15 May 2024) 410.23
Short % of float (15 May 2024) 44.73%
Short % of shares outstanding (15 May 2024) 43.79%
Shares short (prior month 15 Apr 2024) 41.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 308 Mar 2023
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 308 Mar 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-574.33%

Management effectiveness

Return on assets (ttm)-46.36%
Return on equity (ttm)-167.51%

Income statement

Revenue (ttm)15.07M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
EBITDA -81.44M
Net income avi to common (ttm)-81.22M
Diluted EPS (ttm)-1.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)58.06M
Total cash per share (mrq)1.4
Total debt (mrq)7.49M
Total debt/equity (mrq)68.76%
Current ratio (mrq)4.64
Book value per share (mrq)0.26

Cash flow statement

Operating cash flow (ttm)-78.07M
Levered free cash flow (ttm)-53.14M